Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

γδ T cells develop, respond and survive - with a little help from CD27.

Born WK, O'Brien RL.

Eur J Immunol. 2011 Jan;41(1):26-8. doi: 10.1002/eji.201041270. Epub 2010 Dec 9.

2.

CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes.

DeBarros A, Chaves-Ferreira M, d'Orey F, Ribot JC, Silva-Santos B.

Eur J Immunol. 2011 Jan;41(1):195-201. doi: 10.1002/eji.201040905. Epub 2010 Dec 3.

3.

Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.

Hintzen RQ, Lens SM, Lammers K, Kuiper H, Beckmann MP, van Lier RA.

J Immunol. 1995 Mar 15;154(6):2612-23.

PMID:
7876536
4.

Skewed representation of functionally distinct populations of Vgamma9Vdelta2 T lymphocytes in aging.

Re F, Poccia F, Donnini A, Bartozzi B, Bernardini G, Provinciali M.

Exp Gerontol. 2005 Jan-Feb;40(1-2):59-66.

PMID:
15664733
5.

Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions.

Beishuizen CR, Kragten NA, Boon L, Nolte MA, van Lier RA, van Gisbergen KP.

J Immunol. 2009 Nov 15;183(10):6442-51. doi: 10.4049/jimmunol.0901565. Epub 2009 Oct 28.

6.

Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.

Schilbach K, Frommer K, Meier S, Handgretinger R, Eyrich M.

J Immunother. 2008 Nov-Dec;31(9):896-905. doi: 10.1097/CJI.0b013e31818955ad.

PMID:
18832998
7.

CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets.

Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ, Silva-Santos B.

Nat Immunol. 2009 Apr;10(4):427-36. doi: 10.1038/ni.1717. Epub 2009 Mar 8.

8.

Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells.

Lens SM, Baars PA, Hooibrink B, van Oers MH, van Lier RA.

Immunology. 1997 Jan;90(1):38-45.

10.

Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.

Correia DV, d'Orey F, Cardoso BA, Lança T, Grosso AR, deBarros A, Martins LR, Barata JT, Silva-Santos B.

PLoS One. 2009 May 21;4(5):e5657. doi: 10.1371/journal.pone.0005657.

11.

CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.

Poccia F, Cipriani B, Vendetti S, Colizzi V, Poquet Y, Battistini L, López-Botet M, Fournié JJ, Gougeon ML.

J Immunol. 1997 Dec 15;159(12):6009-17.

PMID:
9550399
12.

Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis.

Nakajima A, Oshima H, Nohara C, Morimoto S, Yoshino S, Kobata T, Yagita H, Okumura K.

J Neuroimmunol. 2000 Sep 22;109(2):188-96.

PMID:
10996221
13.

Murine T cell determination of pregnancy outcome: I. Effects of strain, alphabeta T cell receptor, gammadelta T cell receptor, and gammadelta T cell subsets.

Arck PC, Ferrick DA, Steele-Norwood D, Croitoru K, Clark DA.

Am J Reprod Immunol. 1997 Jun;37(6):492-502. Erratum in: Am J Reprod Immunol 1997 Dec;38(6):438.

PMID:
9228307
14.

CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development.

van Oosterwijk MF, Juwana H, Arens R, Tesselaar K, van Oers MH, Eldering E, van Lier RA.

Int Immunol. 2007 Jun;19(6):713-8. Epub 2007 Jun 4.

PMID:
17548342
15.

Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.

Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H, Smyth MJ.

Nat Immunol. 2002 Jan;3(1):83-90. Epub 2001 Dec 17.

PMID:
11743585
16.

Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.

Ranheim EA, Cantwell MJ, Kipps TJ.

Blood. 1995 Jun 15;85(12):3556-65.

17.

IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.

Thedrez A, Harly C, Morice A, Salot S, Bonneville M, Scotet E.

J Immunol. 2009 Mar 15;182(6):3423-31. doi: 10.4049/jimmunol.0803068.

18.

NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.

Nedellec S, Sabourin C, Bonneville M, Scotet E.

J Immunol. 2010 Jul 1;185(1):55-63. doi: 10.4049/jimmunol.1000373. Epub 2010 May 28.

19.

Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.

Bouet-Toussaint F, Cabillic F, Toutirais O, Le Gallo M, Thomas de la Pintière C, Daniel P, Genetet N, Meunier B, Dupont-Bierre E, Boudjema K, Catros V.

Cancer Immunol Immunother. 2008 Apr;57(4):531-9. Epub 2007 Sep 1.

PMID:
17764010

Supplemental Content

Support Center